UBS O'Connor »

Esperion Therapeutics shares owned by UBS O'Connor

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by UBS O'Connor from 13F filings

Historical chart of UBS O'Connor investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by UBS O'Connor

Quarter filed Position value Share count Share price at filing
2023-09-30 $619k 632k 0.98
2023-06-30 $413k 297k 1.39
2023-03-31 $328k 206k 1.59
2022-12-31 $274k 216k 1.26
2022-09-30 $516k 77k 6.70